The role of TNF-α during Wallerian degeneration
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 108 (1-2) , 147-152
- https://doi.org/10.1016/s0165-5728(00)00262-9
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Tumour necrosis factor‐alpha (TNF‐α): The good, the bad and potentially very effectiveImmunology & Cell Biology, 1996
- Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosisJournal of Neuroimmunology, 1996
- Schwann cells degrade myelin and proliferate in the absence of macrophages: evidence fromin vitro studies of Wallerian degenerationJournal of Neurocytology, 1995
- Actions of the chemotactic cytokines MCP‐1, MCP‐2, MCP‐3, RANTES, MIP‐1α and MIP‐1β on human monocytesEuropean Journal of Immunology, 1995
- Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitisJournal of Neuroimmunology, 1994
- Kinetics of TNF, IL-6, and IL-8 gene expression in LPS-stimulated human whole bloodBiochemical and Biophysical Research Communications, 1991
- Wallerian degeneration in the peripheral nervous system: participation of both Schwann cells and macrophages in myelin degradationJournal of Neurocytology, 1989
- A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: Ramifications for the complex physiology of TNFCell, 1988
- The role of non-resident cells in Wallerian degenerationJournal of Neurocytology, 1984